Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2015, Article ID 908087, 5 pages
http://dx.doi.org/10.1155/2015/908087
Case Report

Necrotizing Fasciitis in Paroxysmal Nocturnal Hemoglobinuria

1Department of Hematology, Ege University, 35100 Izmir, Turkey
2Department of Plastic and Reconstructive Surgery, Ege University, 35100 Izmir, Turkey
3Department of General Surgery, Ege University, 35100 Izmir, Turkey
4Department of Internal Medicine, Tepecik Education and Training Hospital, Izmir, Turkey
5Department of Immunology, Ege University, 35100 Izmir, Turkey

Received 14 June 2015; Revised 2 August 2015; Accepted 3 August 2015

Academic Editor: Kostas Konstantopoulos

Copyright © 2015 Pusem Patir et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Schubert, P. Uciechowski, P. Delany, H.-J. Tischler, W. Kolanus, and R. E. Schmidt, “The PIG-anchoring defect in NK lymphocytes of PNH patients,” Blood, vol. 76, no. 6, pp. 1181–1187, 1990. View at Google Scholar · View at Scopus
  2. H. Nakakuma, S. Nagakura, K. Horikawa et al., “Interleukin-2-dependent T-cell lines established from paroxysmal nocturnal hemoglobinuria patients,” Blood, vol. 84, no. 1, pp. 309–314, 1994. View at Google Scholar · View at Scopus
  3. P. Hillmen, J. M. Hows, and L. Luzzatto, “Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria,” British Journal of Haematology, vol. 80, no. 3, pp. 399–405, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Takeda, T. Miyata, K. Kawagoe et al., “Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria,” Cell, vol. 73, no. 4, pp. 703–711, 1993. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Armstrong, J. Schubert, E. Ueda et al., “Affected paroxysmal nocturnal hemoglobinuria T lymphocytes harbor a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A Thy-1- murine lymphoma mutants,” The Journal of Biological Chemistry, vol. 267, no. 35, pp. 25347–25351, 1992. View at Google Scholar · View at Scopus
  6. P. Hillmen, M. Bessler, P. J. Mason, W. M. Watkins, and L. Luzzatto, “Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 11, pp. 5272–5276, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Takahashi, J. Takeda, S. Hirose et al., “Deficient biosynthesis of N-acetylglucosaminyl-phosphatidylinositol, the first intermediate of glycosyl phosphatidylinositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria,” The Journal of Experimental Medicine, vol. 177, no. 2, pp. 517–521, 1993. View at Publisher · View at Google Scholar · View at Scopus
  8. M. H. Holguin, L. R. Fredrick, N. J. Bernshaw, L. A. Wilcox, and C. J. Parker, “Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria,” Journal of Clinical Investigation, vol. 84, no. 1, pp. 7–17, 1989. View at Publisher · View at Google Scholar · View at Scopus
  9. W. F. Rosse, “Paroxysmal nocturnal hemoglobinuria,” in Hematology, W. J. Williams, E. Beutler, A. J. Erslev, and R. W. Rundles, Eds., pp. 460–474, McGraw-Hill Book, New York, NY, USA, 1972. View at Google Scholar
  10. W. F. Rosse and C. J. Parker, “Paroxysmal nocturnal haemoglobinuria,” Clinics in Haematology, vol. 14, no. 1, pp. 105–125, 1985. View at Google Scholar · View at Scopus
  11. M. L. Ge, X. X. Li, Y. Q. Shao, J. Shi, and Y. Z. Zheng, “Clinical analysis of 70 adult patients with paroxysmal nocturnal hemoglobinuria,” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 23, no. 3, pp. 774–778, 2015. View at Google Scholar
  12. R. J. Green, D. C. Dafoe, and T. A. Raffin, “Necrotizing fasciitis,” Chest, vol. 110, no. 1, pp. 219–229, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. D. V. Seal, “Necrotizing fasciitis,” Current Opinion in Infectious Diseases, vol. 14, no. 2, pp. 127–132, 2001. View at Publisher · View at Google Scholar
  14. W. J. Rea and W. J. Wyrick Jr., “Necrotizing fasciitis,” Annals of Surgery, vol. 172, no. 6, pp. 957–964, 1970. View at Publisher · View at Google Scholar · View at Scopus
  15. C. R. McHenry, J. J. Piotrowski, D. Petrinic, and M. A. Malangoni, “Determinants of mortality for necrotizing soft-tissue infections,” Annals of Surgery, vol. 221, no. 5, pp. 558–565, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. S. G. Watt, S. Winhoven, C. R. M. Hay, and G. S. Lucas, “Purpura fulminans in paroxysmal nocturnal haemoglobinuria,” British Journal of Haematology, vol. 137, article 271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. C.-H. Wong, H.-C. Chang, S. Pasupathy, L.-W. Khin, J.-L. Tan, and C.-O. Low, “Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality,” The Journal of Bone & Joint Surgery—American Volume, vol. 85, no. 8, pp. 1454–1460, 2003. View at Google Scholar · View at Scopus
  18. M. S. Dworkin, M. D. Westercamp, L. Park, and A. McIntyre, “The epidemiology of necrotizing fasciitis including factors associated with death and amputation,” Epidemiology and Infection, vol. 137, no. 11, pp. 1609–1614, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Golger, S. Ching, C. H. Goldsmith, R. A. Pennie, and J. R. Bain, “Mortality in patients with necrotizing fasciitis,” Plastic and Reconstructive Surgery, vol. 119, no. 6, pp. 1803–1807, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. D. A. Anaya and E. P. Dellinger, “Necrotizing soft-tissue infection: diagnosis and management,” Clinical Infectious Diseases, vol. 44, no. 5, pp. 705–710, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. C.-Y. Lee, L.-T. Kuo, K.-T. Peng, W.-H. Hsu, T.-W. Huang, and Y.-C. Chou, “Prognostic factors and monomicrobial necrotizing fasciitis: gram-positive versus gram-negative pathogens,” BMC Infectious Diseases, vol. 11, article 5, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Hillmen, N. S. Young, J. Schubert et al., “The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria,” The New England Journal of Medicine, vol. 355, no. 12, pp. 1233–1243, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. R. A. Brodsky, N. S. Young, E. Antonioli et al., “Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria,” Blood, vol. 111, no. 4, pp. 1840–1847, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Hill, R. P. Rother, X. Wang et al., “Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria,” British Journal of Haematology, vol. 149, no. 3, pp. 414–425, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. R. P. Rother, L. Bell, P. Hillmen, and M. T. Gladwin, “The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: ش novel mechanism of human disease,” Journal of the American Medical Association, vol. 293, no. 13, pp. 1653–1662, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Hillmen, M. Elebute, R. Kelly et al., “Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria,” American Journal of Hematology, vol. 85, no. 8, pp. 553–559, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Hillmen, P. Muus, U. Dührsen et al., “Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria,” Blood, vol. 110, no. 12, pp. 4123–4128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Hillmen, C. Hall, J. C. W. Marsh et al., “Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria,” The New England Journal of Medicine, vol. 350, no. 6, pp. 552–559, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. R. J. Kelly, A. Hill, L. M. Arnold et al., “Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival,” Blood, vol. 117, no. 25, pp. 6786–6792, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. P. D. Kumar, “Recurrent necrotizing fasciitis in complement C4 deficiency,” Annals of Internal Medicine, vol. 135, no. 8, article 635, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Agrahari, Z. Liang, J. A. Mayfield, R. D. Balsara, V. A. Ploplis, and F. J. Castellino, “Complement-mediated opsonization of invasive group A Streptococcus pyogenes strain AP53 is regulated by the bacterial two-component cluster of virulence responder/sensor (CovRS) system,” Journal of Biological Chemistry, vol. 288, no. 38, pp. 27494–27504, 2013. View at Publisher · View at Google Scholar · View at Scopus